Karna Dev Bardhan

6.6k total citations · 1 hit paper
153 papers, 5.1k citations indexed

About

Karna Dev Bardhan is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karna Dev Bardhan has authored 153 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Surgery, 73 papers in Gastroenterology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karna Dev Bardhan's work include Helicobacter pylori-related gastroenterology studies (80 papers), Gastroesophageal reflux and treatments (59 papers) and Eosinophilic Esophagitis (41 papers). Karna Dev Bardhan is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (80 papers), Gastroesophageal reflux and treatments (59 papers) and Eosinophilic Esophagitis (41 papers). Karna Dev Bardhan collaborates with scholars based in United Kingdom, Germany and Canada. Karna Dev Bardhan's co-authors include Colm O’Morain, E. Bayerdörffer, Tore Lind, David Armstrong, Ramesh Arasaradnam, Chuka Nwokolo, Peter Unge, Sander Veldhuyzen van Zanten, C. Cederberg and Robert E. Spiller and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Karna Dev Bardhan

152 papers receiving 4.8k citations

Hit Papers

Eradication of Helicobacter pylori Using One‐week Triple ... 1996 2026 2006 2016 1996 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karna Dev Bardhan United Kingdom 38 3.5k 2.8k 968 614 393 153 5.1k
G. D. Bell United Kingdom 41 2.6k 0.7× 884 0.3× 1.4k 1.5× 170 0.3× 401 1.0× 134 5.1k
A. L. Blum Switzerland 41 5.4k 1.5× 4.3k 1.5× 1.0k 1.1× 60 0.1× 688 1.8× 165 7.4k
J J Misiewicz United Kingdom 48 4.8k 1.4× 3.5k 1.3× 1.4k 1.4× 64 0.1× 443 1.1× 158 7.8k
Chuka Nwokolo United Kingdom 29 896 0.3× 499 0.2× 352 0.4× 764 1.2× 497 1.3× 102 2.6k
David A. Peura United States 32 2.5k 0.7× 1.7k 0.6× 852 0.9× 30 0.0× 221 0.6× 114 3.8k
Greger Lindberg Sweden 43 3.1k 0.9× 3.0k 1.1× 786 0.8× 49 0.1× 663 1.7× 123 7.4k
George Triadafilopoulos United States 52 6.4k 1.8× 4.2k 1.5× 2.4k 2.5× 89 0.1× 822 2.1× 348 10.4k
Hye‐Kyung Jung South Korea 34 2.3k 0.7× 2.3k 0.8× 877 0.9× 25 0.0× 355 0.9× 201 4.2k
Jeffrey L. Barnett United States 34 1.6k 0.5× 1.2k 0.4× 709 0.7× 70 0.1× 339 0.9× 71 4.1k
Mark Fox Switzerland 52 7.4k 2.1× 8.0k 2.9× 781 0.8× 134 0.2× 307 0.8× 201 10.6k

Countries citing papers authored by Karna Dev Bardhan

Since Specialization
Citations

This map shows the geographic impact of Karna Dev Bardhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karna Dev Bardhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karna Dev Bardhan more than expected).

Fields of papers citing papers by Karna Dev Bardhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karna Dev Bardhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karna Dev Bardhan. The network helps show where Karna Dev Bardhan may publish in the future.

Co-authorship network of co-authors of Karna Dev Bardhan

This figure shows the co-authorship network connecting the top 25 collaborators of Karna Dev Bardhan. A scholar is included among the top collaborators of Karna Dev Bardhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karna Dev Bardhan. Karna Dev Bardhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pattni, Sanjeev, W. G. Brydon, Tracy Dew, et al.. (2013). Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Alimentary Pharmacology & Therapeutics. 38(8). 967–976. 95 indexed citations
2.
Arasaradnam, Ramesh, M. Joseph, Chuka Nwokolo, et al.. (2011). Radiation-induced gut damage: identifying ‘at risk' patients with an ‘electronic nose' (E-NOSE): Table 1. Gut. 60(Suppl 1). A108.2–A109. 1 indexed citations
3.
González-Correa, Carlos-Augusto, Brian Brown, R. H. Smallwood, Dawn Walker, & Karna Dev Bardhan. (2005). Electrical bioimpedance readings increase with higher pressure applied to the measuring probe. Physiological Measurement. 26(2). S39–S47. 41 indexed citations
4.
Bardhan, Karna Dev, et al.. (2004). Admission rates for peptic ulcer in the Trent Region, UK, 1972–2000. Digestive and Liver Disease. 36(9). 577–588. 33 indexed citations
5.
Bardhan, Karna Dev. (2003). Intermittent and on-Demand Use of Proton Pump Inhibitors in The Management of Symptomatic Gastroesophageal Reflux Disease. The American Journal of Gastroenterology. 98(3 Suppl). S40–S48. 43 indexed citations
6.
Bardhan, Karna Dev, Rachel Jones, M. Thompson, et al.. (1998). Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo. Gut. 43(4). 458–464. 16 indexed citations
8.
Read, N. W., Jean‐Louis Abitbol, Karna Dev Bardhan, Peter J. Whorwell, & B Fraitag. (1997). Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut. 41(5). 664–668. 86 indexed citations
9.
Price, Ashley B., et al.. (1995). Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.. Gut. 37(2). 195–198. 11 indexed citations
10.
Bardhan, Karna Dev, et al.. (1993). Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.. Gut. 34(10). 1310–1314. 12 indexed citations
11.
Bardhan, Karna Dev, J. Næsdal, G. Bianchi Porro, et al.. (1991). Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.. Gut. 32(4). 435–438. 32 indexed citations
12.
Bardhan, Karna Dev, Pamela J. Morris, M. Thompson, et al.. (1990). Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.. Gut. 31(7). 745–749. 52 indexed citations
13.
Bardhan, Karna Dev, Pamela J. Morris, R F Hinchliffe, et al.. (1989). A comparison of low‐dose maintenance treatment with enprostil against ranitidine in the prevention of duodenal ulcer recurrence. Alimentary Pharmacology & Therapeutics. 3(5). 489–497. 2 indexed citations
14.
Bardhan, Karna Dev, R F Hinchliffe, Pamela J. Morris, et al.. (1988). A Comparison of Enprostil and Ranitidine in Treatment of Duodenal Ulcer. Journal of Clinical Gastroenterology. 10(2). 137–142. 7 indexed citations
15.
Bardhan, Karna Dev, John O. Hunter, J. Philip Miller, et al.. (1988). Antacid maintenance therapy in the prevention of duodenal ulcer relapse.. Gut. 29(12). 1748–1754. 19 indexed citations
16.
Bardhan, Karna Dev, M. Thompson, R F Hinchliffe, et al.. (1987). Combined anti-muscarinic and H2 receptor blockade in the healing of refractory duodenal ulcer. A double blind study.. Gut. 28(11). 1505–1509. 17 indexed citations
17.
Bardhan, Karna Dev. (1984). Refractory duodenal ulcer.. Gut. 25(7). 711–717. 87 indexed citations
18.
Bardhan, Karna Dev. (1980). Intermittent treatment of duodenal ulcer with cimetidine.. BMJ. 281(6232). 20–22. 50 indexed citations
19.
Bardhan, Karna Dev, et al.. (1979). Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration.. Gut. 20(2). 158–162. 61 indexed citations
20.
Bardhan, Karna Dev, et al.. (1976). Proceedings: Deglycyrrhizinated liquorice in gastric ulcer: a double blind controlled study.. PubMed. 17(5). 397–397. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026